Top compounds associated with response to TTC34


Feature Type Standardized
Nominal ANOVA
mRNA tamatinib CTRPv2 pan-cancer AAC -0.052 0.2
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.05 0.2
mRNA ML210 CTRPv2 pan-cancer AAC 0.045 0.2
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC -0.051 0.2
mRNA procarbazine CTRPv2 pan-cancer AAC -0.053 0.2
mRNA BRD-K37390332 CTRPv2 pan-cancer AAC 0.053 0.2
mRNA NSC 74859 CTRPv2 pan-cancer AAC -0.052 0.2
mRNA cimetidine CTRPv2 pan-cancer AAC 0.09 0.2
mRNA Docetaxel gCSI pan-cancer AAC -0.071 0.2
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
Download CSV